All trials
NCT07512362PHASE2NOT YET RECRUITING

Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.

Eligibility check — Phoenix members

Phoenix members see for THIS trial:

  • APOE genotype match
  • Cognitive status fits inclusion
  • Specific exclusions flagged
  • Distance to nearest site
Check my eligibility — become a member
Sites
1 location
Start
2026-06-15

Interventions tested

  • BIOLOGICALhuman Mesenchymal Stem Cells
View full record on ClinicalTrials.gov

We use cookies to enhance your experience.